Search Results

Immobilization Hypercalcemia-Associated Acute Renal Failure in a Patient with Chronic Tophaceous Gout

Authors: Lee, Kyung-Ae; Yoo, Wan-Hee

Source: Renal Failure, Volume 31, Number 9, October 2009 , pp. 855-857(3)

Publisher: Informa Healthcare

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case

Authors: Shirota, Tatsuo; Nakamura, Atsushi; Matsui, Yoshiro; Hatori, Masahi; Nakamura, Masanori; Shintani, Satoru

Source: Clinical Oral Implants Research, Volume 20, Number 12, December 2009 , pp. 1402-1408(7)

Publisher: Blackwell Publishing

Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

Authors: Saad, Fred; Abrahamsson, Per-Anders; Miller, Kurt

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1573-1579(7)

Publisher: Blackwell Publishing

Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis

Authors: Planas, Jacques; Trilla, Enrique; Raventós, Carles; Cecchini, Lluis; Orsola, Anna; Salvador, Carles; Placer, Jose; Encabo, Gloria; Morote, Juan

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1637-1640(4)

Publisher: Blackwell Publishing

Bisphosphonates and oral surgery

Author: Oliver, R.

Source: Oral Surgery, Volume 2, Number 2, May 2009 , pp. 56-63(8)

Publisher: Blackwell Publishing

Palliativtherapie eines nichtkleinzelligen Bronchialkarzinoms

Authors: Papke, J.; Mizera, E.

Source: Der Pneumologe, Volume 6, Number 4, July 2009 , pp. 246-250(5)

Publisher: Springer

Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures

Authors: Sheehy, O.; Kindundu, C.; Barbeau, M.; LeLorier, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1583-1594(12)

Publisher: Springer

Osteoporosis management among residents living in long-term care

Authors: Giangregorio, L.; Jantzi, M.; Papaioannou, A.; Hirdes, J.; Maxwell, C.; Poss, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1471-1478(8)

Publisher: Springer

Agents Targeting Prostate Cancer Bone Metastasis

Authors: Mohammad, Khalid S.; Fournier, Pierrick G.; Guise, Theresa A.; Chirgwin, John M.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 10, December 2009 , pp. 1079-1088(10)

Publisher: Bentham Science Publishers

Effects of Bisphosphonate on the Endochondral Bone Formation of the Mandibular Condyle

Authors: Kim, M. S.; Jung, S. Y.; Kang, J. H.; Kim, H. J.; Ko, H. M.; Jung, J. Y.; Koh, J. T.; Kim, W. J.; Kim, S. M.; Lee, E. J.; Kim, S. H.

Source: Anatomia, Histologia, Embryologia, Volume 38, Number 5, October 2009 , pp. 321-326(6)

Publisher: Blackwell Publishing

Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's bone disease

Author: Doggrell, Sheila A

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 5, September 2009 , pp. 405-415(11)

Publisher: Expert Reviews

Paget's disease of bone: emphasis on treatment with zoledronic acid

Authors: Polyzos, Stergios A; Anastasilakis, Athanasios D; Terpos, Evangelos

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 5, September 2009 , pp. 423-434(12)

Publisher: Expert Reviews

Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective

Author: Boonen, Steven

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2335-2341(7)

Publisher: Informa Healthcare

Management of osteoporosis in the elderly

Authors: Rizzoli, R.; Bruyere, O.; Cannata-Andia, J. B.; Devogelaer, J.-P.; Lyritis, G.; Ringe, J. D.; Vellas, B.; Reginster, J.-Y.

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2373-2387(15)

Publisher: Informa Healthcare

Clinical efficacy and safety of zoledronic acid in prostate and breast cancer

Author: Doggrell, Sheila A

Source: Expert Review of Anticancer Therapy, Volume 9, Number 9, September 2009 , pp. 1211-1218(8)

Publisher: Expert Reviews

Dental management of patients at risk of osteochemonecrosis of the jaws: a critical review

Authors: Fedele, S; Kumar, N; Davies, R; Fiske, J; Greening, S; Porter, S

Source: Oral Diseases, Volume 15, Number 8, November 2009 , pp. 527-537(11)

Publisher: Blackwell Publishing

Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review

Authors: Diel, Ingo; Weide, Rudolf; Köppler, Hubert; Antràs, Lucia; Smith, Michael; Green, Jesse; Wintfeld, Neil; Neary, Maureen; Duh, Mei

Source: Supportive Care in Cancer, Volume 17, Number 6, June 2009 , pp. 719-725(7)

Publisher: Springer

Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid

Authors: Rossini, Maurizio; Viapiana, Ombretta; Ramonda, Roberta; Bianchi, Gerolamo; Olivieri, Ignazio; Lapadula, Giovanni; Adami, Silvano

Source: Rheumatology, Volume 48, Number 7, 4 July 2009 , pp. 773-778(6)

Publisher: Oxford University Press

Model to optimise the amount of drug on an implant used as drug delivery system

Authors: Stadelmann, V. A.; Gauthier, O.; Bouler, J. M.; Terrier, A.; Pioletti, D. P.

Source: Computer Methods in Biomechanics and Biomedical Engineering, Volume 12, Supplement 1, August 2009 , pp. 233-234(2)

Publisher: Taylor and Francis Ltd